Wang Yu-Ming, Wang Chong-Jong, Fang Fu-Min, Chen Hui-Chun, Hsu Hsuan-Chih, Huang Yu-Jie, Wang Chang-Yu, Huang Eng-Yen
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; School of Traditional Chinese Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan; Institute of Physiology, National Yang-Ming University, Taipei, Taiwan.
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Gynecol Oncol. 2017 May;145(2):277-283. doi: 10.1016/j.ygyno.2017.02.034. Epub 2017 Mar 6.
To evaluate the differences in the treatment outcomes and complications between elderly patients and younger patients with uterine cervical cancer (CxCa).
From April 1993 to December 2007, 138 CxCa patients aged ≥75years (Elderly group) and 334 CxCa patients aged <60years (Young group) who underwent definitive radiotherapy/chemoradiotherapy at our institution were reviewed. Two propensity score-matched cohorts of patients were selected from both age groups to evaluate the differences in the outcomes and complications. The overall survival (OS), cancer-specific survival (CSS), local failure (LF), distant failure (DF), late proctitis, and cystitis were compared between the age groups.
The median follow-up time for survivors was 60.6months. A cohort of 99 pairs of patients was selected for the outcome comparison; there was a significant difference in the 5-year OS between the Elderly and Young groups (49.2% and 71.5%, respectively; p<0.001) but no differences in CSS, LF, and DF. Another cohort of 79 pairs of patients was selected for complication analysis. Significant differences between the Elderly and Young groups were observed in the 5-year cumulative grade 2 proctitis (39.7% and 17.2%, respectively; p=0.015) and grade 3 proctitis (18.1% and 6.2%, respectively; p=0.040).
Although OS was worse in the elderly patients, no differences were observed in CSS, LF, and DF. Meanwhile, elderly patients tended to have higher radiation-related proctitis than younger patients. A more conservative treatment strategy for elderly CxCa patients is reasonable in our future practice.
评估老年子宫颈癌(CxCa)患者与年轻患者在治疗结局及并发症方面的差异。
回顾1993年4月至2007年12月在我院接受根治性放疗/放化疗的138例年龄≥75岁的CxCa患者(老年组)和334例年龄<60岁的CxCa患者(年轻组)。从两个年龄组中选取两个倾向评分匹配的患者队列,以评估结局和并发症的差异。比较年龄组之间的总生存期(OS)、癌症特异性生存期(CSS)、局部失败(LF)、远处失败(DF)、晚期直肠炎和膀胱炎。
幸存者的中位随访时间为60.6个月。选取99对患者进行结局比较;老年组和年轻组的5年OS有显著差异(分别为49.2%和71.5%;p<0.001),但CSS、LF和DF无差异。选取79对患者进行并发症分析。老年组和年轻组在5年累积2级直肠炎(分别为39.7%和17.2%;p = 0.015)和3级直肠炎(分别为18.1%和6.2%;p = 0.040)方面存在显著差异。
尽管老年患者的OS较差,但CSS、LF和DF无差异。同时,老年患者的放射性直肠炎往往比年轻患者更高。在我们未来的实践中,对老年CxCa患者采取更保守的治疗策略是合理的。